An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking Methods
Unlike organic molecules, reports on docking of metal complexes are very few; mainly due to the inadequacy of force fields in docking packages to appropriately characterize the metal atoms that consequentially hinder the rational design of metal-based drug complexes. In this study we have made used...
Main Authors: | Peter A. Ajibade, Adebayo A. Adeniyi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/18/9/10829 |
Similar Items
-
Comparing the Suitability of Autodock, Gold and Glide for the Docking and Predicting the Possible Targets of Ru(II)-Based Complexes as Anticancer Agents
by: Adebayo A. Adeniyi, et al.
Published: (2013-03-01) -
Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?
by: James P. C. Coverdale, et al.
Published: (2019-03-01) -
Investigations on the Anticancer Potential of Benzothiazole-Based Metallacycles
by: Stephan Mokesch, et al.
Published: (2020-04-01) -
Synthesis, anticancer activity and molecular docking study of Schiff base complexes containing thiazole moiety
by: Mokhles M. Abd-Elzaher, et al.
Published: (2016-03-01) -
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
by: Claudia Riccardi, et al.
Published: (2019-09-01)